Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242722 · ClinicalTrials.gov registry record
Evaluation of Left Ventricular Autothreshold, Phase Two
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 100
- Enrollment target
NCT01242722 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 100 participants.
The verdict
NCT01242722 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study will collect data, from an implanted Cardiac Resynchronization Therapy-Defibrillator (CRT-D) device, to further evaluate a new feature for future heart failure devices.
Interventions
- DEVICE CRT-D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01242722
The ClinicalTrials.gov registry entry for NCT01242722 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRT-D is the first listed.
NCT01242722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01242722 about?
NCT01242722 is a clinical study titled "Evaluation of Left Ventricular Autothreshold, Phase Two". This study will collect data, from an implanted Cardiac Resynchronization Therapy-Defibrillator (CRT-D) device, to further evaluate a new feature for future heart failure devices.
What is the current status of trial NCT01242722?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2010-11. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01242722?
The interventions under investigation include: CRT-D (DEVICE).
Who is sponsoring clinical trial NCT01242722?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.